MM	multiple myeloma
BM	bone marrow
PL	plasma
ctDNA	cell free tumour DNA
ND	newly diagnosed
RR	relapsed and/or refractory
OMD	OnTargetTM mutation detection platform
TAS	targeted amplicon sequencing
FA	fractional abundance
PFS	progression-free survival
OS	overall survival
AF	allele frequency